Trials / Completed
CompletedNCT00929734
Effect of Rosuvastatin Therapy in Patients With Stable Chronic Obstructive Pulmonary Disease
Effect of ROsuvastatin Therapy on Peripheral Vasodilator Function, Inflammatory Markers and Pulmonary Function in Patients With StablE Chronic Obstructive Pulmonary Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 99 (actual)
- Sponsor
- University Hospital, Akershus · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate whether rosuvastatin improves measures of endothelial function, decreases measures of inflammation, and improves pulmonary function in patients with stable chronic obstructive pulmonary disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin | 10mg tablets, once daily in three months |
| DRUG | Placebo | 1 tablet, once daily in three months |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2009-06-29
- Last updated
- 2015-10-08
- Results posted
- 2015-10-08
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00929734. Inclusion in this directory is not an endorsement.